Corbus Pharmaceuticals(CRBP) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Corbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update Norwood, MA, August 5, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage oncology and obesity company, today provided a corporate update and reported financial results for the quarter ended June 30, 2025. "The second half of 2025 is shaping up to be impactful, with scheduled data readouts anticipated for all three of our c ...